Brief: Oncopeptides Q2 Net Loss Widens To SEK 59.8 Million
11/08/2022 07:20
Aug 11 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES PUBLISHES Q2 REPORT 2022
* Q2 NET SALES AMOUNTED TO SEK 8.8 M (66.4)
* Q2 NET RESULT AMOUNTED TO SEK -59.8 M (-24.1)
Source text for Eikon: ID:nWkr10Wj2G
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy